Quick Answer
As of September 26, 2026, there is no universal semaglutide units-to-mg conversion. The unit marks on an insulin syringe measure a volume of liquid, not an amount of semaglutide. How much semaglutide that volume holds depends on the concentration (milligrams per milliliter) printed on your vial label, and that concentration can differ from one pharmacy to another and from one refill to the next. The only valid conversion for your vial is the one your pharmacist wrote on the label and your prescriber wrote in your instructions. If the two do not agree, do not inject. Call the pharmacy first.
What the "units" on an insulin syringe actually mean
When compounded semaglutide is dispensed in a multi-dose vial, each dose is drawn with a syringe, most often one printed with an insulin unit scale. The scale on that syringe is printed in units. This is where most confusion starts, because the word "unit" sounds like it should measure the drug. It does not.
Insulin syringes were designed for insulin, and their unit scale was built around a standard insulin concentration. MedlinePlus, published by the National Library of Medicine, puts the principle plainly: "The type of insulin should match the type of syringe". The scale only makes sense for the concentration it was designed for. When a different liquid is drawn into the same syringe, each unit mark still measures the same volume of liquid, but the amount of drug in that volume is whatever the vial's concentration says it is.
So a unit mark is a volume mark. It tells you how much liquid you have drawn. It cannot tell you how much semaglutide is in that liquid, because the syringe has no way of knowing what is in the vial.
Why milligrams per unit depend on the label
The bridge between the syringe scale and the amount of semaglutide is the concentration printed on your pharmacy label, expressed as milligrams per milliliter. A vial with a higher concentration packs more semaglutide into the same volume, so a given prescribed amount takes up less space in the syringe. A vial with a lower concentration holds less semaglutide in the same volume, so the same prescribed amount takes up more space.
That is the whole reason a generic conversion chart cannot be trusted: it has to assume a concentration, and it has no way of knowing yours. A chart that is correct for one vial is wrong for another. Reading the wrong row changes the amount of semaglutide you inject.
Your pharmacist has already done this arithmetic for the specific vial they dispensed. The label states the concentration, and the directions state the amount to draw for the dose your prescriber ordered. That is the conversion, and it is the only one that applies to the vial in your hand.
Why two vials from two pharmacies can differ
Compounded medications are prepared by individual pharmacies, not by a single manufacturer under one approved label. The concentration on your vial can be different from one pharmacy to another, and the same pharmacy can dispense a different concentration on a later refill, for example when the prescribed amount changes.
Compounded medications are not FDA-approved as final products. In the FDA's own words, "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." There is no standardized, agency-reviewed concentration that every pharmacy uses, which means there is no concentration a chart can safely assume.
The practical consequence: never carry a unit count from one vial to the next. Treat every new vial as a new set of instructions. Read the label, read the directions written for that vial, and if anything looks different from last time, ask before you draw.
The FDA's warning about dosing errors
This is not a theoretical concern. The FDA's drug alert on unapproved weight-loss drugs, including compounded semaglutide, reports that the agency "received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products." It goes on: "These dosing errors resulted from patients measuring and self-administering incorrect doses of the drug, and in some cases, health care professionals miscalculating doses of the drug."
The agency's guidance to patients in the same alert is the guidance this article exists to repeat: the FDA "encourages patients to talk with their health care provider or compounder about how to measure and administer the intended dose of compounded semaglutide or tirzepatide." Not a forum, not a friend on the same medication: the provider who prescribed it and the pharmacy that prepared it.
The only valid source of your conversion
Two documents carry the conversion for your vial:
- The pharmacy label on the vial, which states the concentration and, in the directions, the amount to draw.
- Your prescriber's instructions, which state the dose ordered for you and any adjustment your prescriber has made to it.
Everything else, including this article, is general education. When you receive a new vial, read both documents before the first injection, and confirm the unit mark you are supposed to draw with the pharmacist if the instructions are unclear. MedlinePlus's own instructions for drawing medicine from a vial begin with "Check the label" and describe drawing to "the line on your syringe for your dose," a line that only your pharmacist and prescriber can name for you. Where on the body to inject, and why the site changes with each injection, is a separate question, answered for the brand products by their FDA-approved labels and for a compounded vial by the pharmacy and prescriber; see GLP-1 injection sites.
What to do if the label and the instructions disagree
Do not inject. Call the pharmacy that dispensed the vial before drawing anything, and have both the vial and the written instructions in front of you when you call.
A mismatch often has an ordinary explanation: the instructions were written for a previous concentration, the pharmacy changed the concentration on this refill, a different syringe size was supplied, or a transcription error occurred somewhere between the prescriber and the label. Each is resolved with one phone call. None is resolved by guessing, averaging, or choosing the number that looks familiar.
If the pharmacy is closed, wait. A delayed injection is safer than one measured from the wrong source. If you believe you have already injected an incorrect amount, contact your prescriber or Poison Control right away.
Who decides the dose, and who does not
The dose of semaglutide and any later adjustment to it are clinical decisions that belong to the licensed prescriber who evaluated you. Medication is prescribed only if a licensed physician determines it is appropriate for you. The pharmacist's job is to translate that prescribed amount into a mark on the syringe for the specific vial dispensed. An article, a calculator, a chart, or another patient's experience has no role in either decision.
The syringe measures volume, the label supplies the concentration, the pharmacist does the arithmetic, and the prescriber owns the dose. Borrowing a number from outside that chain is how the dosing errors in the FDA's reports happen.
The bottom line
A unit on an insulin syringe is a volume, not an amount of semaglutide. The amount depends on the concentration printed on your vial, which is why two vials can carry different instructions for the same prescribed dose and why no online chart can know your conversion. Read the label on every vial, follow the instructions your prescriber wrote for that vial, and call the pharmacy the moment the two do not match. For more on how compounded semaglutide is prepared and regulated, see our compounded semaglutide guide.
What the primary sources say
- U.S. Food and Drug Administration, FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (accessed September 26, 2026): "FDA received multiple reports of adverse events, some requiring hospitalization, that may be related to dosing errors associated with compounded injectable semaglutide products."
- U.S. Food and Drug Administration, FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products (accessed September 26, 2026): "health care providers should be vigilant when prescribing and administering compounded semaglutide, as there may be different concentrations available. If uncertain, health care providers should contact the compounder about calculating the correct dose of medication to prescribe or administer."
- U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers (accessed September 26, 2026): "Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed."
- MedlinePlus, National Library of Medicine, Giving an insulin injection (accessed September 26, 2026): "The type of insulin should match the type of syringe"
- MedlinePlus, National Library of Medicine, Drawing medicine out of a vial (accessed September 26, 2026): "Check the label. Make sure you have the right medicine. Check the date on the vial. Do not use medicine that is out of date."
This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Never change your dose or perform a dose conversion on your own; your prescriber's instructions and your pharmacy label are the final authority. Compounded medications are not FDA-approved as final products. Medication is prescribed only if a licensed physician determines it is appropriate.
Frequently Asked Questions
Is one unit of semaglutide the same as one milligram?
No. A unit mark on an insulin syringe is a volume mark, a fixed amount of liquid. How much semaglutide is in that liquid depends on the concentration printed on your vial label, so the same unit mark can hold different amounts of semaglutide from different vials. Only your pharmacist's label and your prescriber's instructions tell you what your unit mark means for your vial.
Why is there no single semaglutide units-to-mg chart?
Because compounded semaglutide is prepared by individual pharmacies, the concentration on the vial can differ between pharmacies and between refills, and the concentration is what links units to milligrams. A chart built for one concentration is wrong for another. Compounded medications are not FDA-approved as final products, and the FDA does not review them before they are marketed, so there is no standard concentration a chart could assume.
Why did my unit count change when I switched pharmacies or got a refill?
One common reason is that the concentration on the new vial is different from the old one. If the new vial holds more semaglutide per milliliter, the same prescribed amount takes up less volume, so the unit mark changes. Treat every new vial as a new set of instructions: read the label, read the prescriber's directions written for that vial, and do not carry over a unit count from an earlier vial.
What should I do if my pharmacy label and my prescriber's instructions disagree?
Do not inject. Call the pharmacy that dispensed the vial and read them both the label and the instructions. A mismatch can mean the instructions were written for a previous concentration, the wrong vial was picked up, or a transcription error occurred. Waiting for one phone call is safer than guessing, averaging, or using a number from a forum.
Can I use a conversion someone posted online or a friend's unit count?
No. Their vial may have a different concentration from yours, so their unit count can be the wrong amount for you. The FDA has received reports of adverse events, some requiring hospitalization, that may be related to dosing errors with compounded injectable semaglutide, including patients measuring and self-administering incorrect doses. The only conversion that applies to you is the one on your own label and in your own prescriber's instructions.
Who decides my semaglutide dose?
A licensed prescriber. The dose and any later adjustment to it are clinical decisions made by the physician who evaluated you and who has determined that the medication is appropriate for you. Your pharmacist translates that prescribed amount into a unit mark for the specific vial they dispensed. Neither role belongs to an article, a chart, or a calculator.
Does this apply to pre-filled pens?
Unit-based measuring with an insulin syringe applies to medication dispensed in a multi-dose vial with a separate syringe, which is one way compounded semaglutide is supplied. If your medication comes in a manufacturer's pre-filled pen, follow the instructions for use that come with that product and the directions from your prescriber. Never assume a measurement from one product form applies to another.
Sources
This article is based on the following primary sources. Links open the original documents.
- 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss · U.S. Food and Drug Administration · accessed
- 2.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (patient guidance on measuring the dose) · U.S. Food and Drug Administration · accessed
- 3.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (compounded drugs are not reviewed before marketing) · U.S. Food and Drug Administration · accessed
- 4.Compounding and the FDA: Questions and Answers · U.S. Food and Drug Administration · accessed
- 5.Giving an insulin injection · MedlinePlus Medical Encyclopedia, National Library of Medicine (NIH) · accessed
- 6.Giving an insulin injection (label check and syringe markings) · MedlinePlus Medical Encyclopedia, National Library of Medicine (NIH) · accessed
- 7.Drawing medicine out of a vial · MedlinePlus Medical Encyclopedia, National Library of Medicine (NIH) · accessed
- 8.FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products · U.S. Food and Drug Administration · accessed
Telehealth prescribing rules differ by state. Read the state-by-state guide.
Majesta Health articles are written against primary sources (FDA labeling, NIH and CDC publications, state statutes) and each one passes a documented compliance review before publication. Where an article cites external sources, they are listed at the end of that article so you can check them yourself. No article currently carries an individual physician review; when a physician reviews an article, that page will show the reviewer's name, NPI and review date.
- Written against primary sources: FDA labeling and safety communications, NIH and CDC publications, state statutes and medical board rules
- Documented compliance review against FDA, FTC and LegitScript requirements before publication
- External sources, where an article cites them, are listed at the end of that article with links to the original documents
- Compounded medications are described as not FDA-approved as final products on every page that mentions them